Emapalumab-Lzsg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mg/2 mL, 50 mg/10 mL
Reference Brands: Gamifant (USA/EU)
Category:
Orphan Drugs
Emapalumab-lzsg is a fully human monoclonal antibody that binds and neutralizes interferon-gamma (IFN-γ), helping to suppress excessive immune activation. It is used in patients with hemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening hyperinflammatory syndrome. By inhibiting IFN-γ activity, it helps restore immune balance in patients unresponsive or intolerant to conventional treatments such as corticosteroids, etoposide, or cyclosporine.
Emapalumab-lzsg is available in Injection
and strengths such as 10 mg/2 mL, 50 mg/10 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Emapalumab-lzsg is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Emapalumab-lzsg can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing